Clover Biopharmaceuticals IPO: Valuation Insights
Clover has launched an IPO to raise net proceeds of $236m at the mid-point of the price range of HK$12.80-13.50 per share. Our valuation analysis...
221 Views
Clover Biopharmaceuticals IPO: Needling
Clover is pre-marketing an HKEx IPO to raise proceeds of $300 m. SCB-2019 (CpG 1018/Alum) is a COVID-19 vaccine candidate which was secured CEPI...
249 Views
Bangkok Expressway (BEM): Ridership Increase
the reopening date is set, and with the support from the Thai government to jump-start the tourism sector, the MRT ridership is set to increase....
180 Views
Technical Analysis on PFIZER INC.
Technical Analysis on PFIZER INC. Financial Highlights& Investment Considerations Pfizer Inc. is an American multinational...
Kintor Pharmaceutical (9939 HK) – Dual Play on COVID and Solid Tumors
Kintor Pharma is set to fly high ahead of its first product launch in China for prostate cancer, which has high unmet medical need. COVID-19...
349 Views